Evaluation of the VersaTREK system compared to the bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis

Mateu Espasa, M. Salvadó, E. Vicente, G. Tudó, F. Alcaide, P. Coll, N. Martin-Casabona, M. Torra, D. Fontanals, J. González-Martín

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Abstract

The aim of this study was to evaluate the reliability of the VersaTREK system for Mycobacterium tuberculosis drug susceptibility testing compared with results obtained with the Bactec MGIT 960 system. A total of 67 strains were evaluated. Overall agreement was at 98.5%. Kappa indexes were 1.0 for isoniazid, rifampin, and ethambutol, 0.937 for pyrazinamide, and 0.907 for streptomycin. The VersaTREK system is validated for M. tuberculosis drug susceptibility testing. Copyright © 2012, American Society for Microbiology. All Rights Reserved.
Original languageEnglish
Pages (from-to)488-491
JournalJournal of Clinical Microbiology
Volume50
Issue number2
DOIs
Publication statusPublished - 1 Feb 2012

Fingerprint Dive into the research topics of 'Evaluation of the VersaTREK system compared to the bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis'. Together they form a unique fingerprint.

Cite this